BCL2 and fibrosarcoma: This finding could be recapitulated for MCA205 fibrosarcomas, which failed to respond to BCL-2 inhibitors upon blockade of CD11b, antibody-mediated depletion of T lymphocytes or in the context of genetically determined athymia (Fig. S9D-H).